15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD for parkinson disease | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |